OBESE
Clinical trials for OBESE explained in plain language.
Never miss a new study
Get alerted when new OBESE trials appear
Sign up with your email to follow new studies for OBESE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Strength training and protein diet may reverse frailty in sarcopenic elderly women
Disease control Recruiting nowThis study investigates whether combining supervised resistance exercise three times a week with a high-protein diet can reduce frailty and improve balance in obese women aged 60–70 who have sarcopenia (age-related muscle loss). Sixty participants are randomly assigned to either …
Matched conditions: OBESE
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New obesity drug HM17321 enters first human safety trials
Disease control Recruiting nowThis early-stage trial is testing a new drug, HM17321, to see if it is safe and how the body processes it. About 90 healthy and obese adults will receive either the drug or a placebo as a shot under the skin. The main goal is to check for side effects, not to treat obesity yet.
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can texts and calls help taxi drivers shed pounds?
Disease control Recruiting nowThis study aims to help overweight or obese taxi and ride-share drivers lose weight through a combination of counseling, text messages, phone support, and self-monitoring tools. Researchers will enroll about 1,785 drivers in New York City to find out which parts of the program wo…
Matched conditions: OBESE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
No needles, no naps: new nose scope could transform gut checks for Weight-Loss patients
Symptom relief Recruiting nowThis study is testing a new, ultra-thin endoscope that goes through the nose without sedation, instead of the usual mouth-and-sedation approach. Researchers want to see if it improves patient experience and lowers costs for people in bariatric care. About 100 adults will try the …
Matched conditions: OBESE
Phase: NA • Sponsor: Christopher C. Thompson, MD, MSc • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to cut nausea in weight loss treatments
Symptom relief Recruiting nowThis early-stage trial is testing whether combining two experimental weight loss drugs—cagrilintide and a GIP receptor agonist—causes fewer stomach side effects like nausea and vomiting compared to taking cagrilintide alone. About 100 women who are overweight or obese will receiv…
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC